Tissue Regenix Group announced the appointment of Gareth Hywel Jones as Chief Financial Officer (CFO). He will join the Group as CFO, company Secretary and as an executive director on the Board on 30 November 2018. Mr. Jones, who will join the Group from Applied Graphene Materials plc is an experienced CFO, bringing significant operational, high technology manufacturing and strategic financial expertise gained through roles in UK and US listed businesses as well as private equity.

Current interim CFO, Paul Below, will remain to facilitate an orderly hand-over.